全文获取类型
收费全文 | 4650篇 |
免费 | 29篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 12篇 |
综合类 | 3篇 |
化学工业 | 144篇 |
金属工艺 | 12篇 |
机械仪表 | 8篇 |
建筑科学 | 33篇 |
矿业工程 | 1篇 |
能源动力 | 18篇 |
轻工业 | 55篇 |
水利工程 | 4篇 |
石油天然气 | 12篇 |
无线电 | 110篇 |
一般工业技术 | 140篇 |
冶金工业 | 4008篇 |
原子能技术 | 3篇 |
自动化技术 | 117篇 |
出版年
2019年 | 6篇 |
2018年 | 10篇 |
2017年 | 14篇 |
2016年 | 15篇 |
2015年 | 11篇 |
2014年 | 13篇 |
2013年 | 33篇 |
2012年 | 22篇 |
2011年 | 34篇 |
2010年 | 16篇 |
2009年 | 16篇 |
2008年 | 25篇 |
2007年 | 43篇 |
2006年 | 28篇 |
2005年 | 21篇 |
2004年 | 23篇 |
2003年 | 22篇 |
2002年 | 24篇 |
2001年 | 21篇 |
2000年 | 19篇 |
1999年 | 155篇 |
1998年 | 1207篇 |
1997年 | 684篇 |
1996年 | 473篇 |
1995年 | 249篇 |
1994年 | 224篇 |
1993年 | 228篇 |
1992年 | 51篇 |
1991年 | 71篇 |
1990年 | 82篇 |
1989年 | 64篇 |
1988年 | 64篇 |
1987年 | 69篇 |
1986年 | 42篇 |
1985年 | 50篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1982年 | 23篇 |
1981年 | 28篇 |
1980年 | 37篇 |
1979年 | 17篇 |
1978年 | 24篇 |
1977年 | 82篇 |
1976年 | 206篇 |
1975年 | 8篇 |
1973年 | 14篇 |
1970年 | 6篇 |
1966年 | 8篇 |
1963年 | 5篇 |
1955年 | 5篇 |
排序方式: 共有4680条查询结果,搜索用时 15 毫秒
31.
JM Karski SJ Teasdale P Norman J Carroll K VanKessel P Wong MF Glynn 《Canadian Metallurgical Quarterly》1995,110(3):835-842
This prospective, double-blind, randomized trial assessed the effectiveness of high-dose tranexamic acid given in the preoperative period on blood loss in patients undergoing cardiopulmonary bypass. One hundred fifty patients scheduled to undergo cardiac operations with cardiopulmonary bypass were randomized into three groups of equal size. The first group received 10 gm of tranexamic acid intravenously over 20 minutes before sternotomy and a placebo infusion over 5 hours. The second group received 10 gm of tranexamic acid over 20 minutes and then another 10 gm infused intravenously over 5 hours. The control group received a placebo bolus and a placebo infusion over 5 hours (0.9% normal saline solution). The blood loss after the operation was measured at 6 hours and 24 hours. The homologous blood and blood products given during and up to 48 hours after operation were recorded. Eighteen percent of the control group patients shed more than 750 ml blood in 6 hours compared with only 2% in both tranexamic acid groups. Patients who shed more than 750 ml blood required 93% more red blood cell transfusions than patients without excessive bleeding. Tranexamic acid (10 gm) given intravenously in the period before cardiopulmonary bypass reduced blood loss over 6 hours by 50% and over 24 hours by 35%. Continued tranexamic acid infusion (10 gm over 5 hours) did not reduce bleeding further. There was no difference in the coagulation profile before operation between patients with and without excessive bleeding. However, coagulation tests done in the postoperative period indicated ongoing fibrinolysis and platelet dysfunction in patients with excessive bleeding. 相似文献
32.
33.
Statistical computer-aided design for microwave circuits 总被引:4,自引:0,他引:4
A useful methodology for microwave circuit design is presented. A statistical technique known as Design of Experiments is used in conjunction with computer-aided design (CAD) tools to obtain simple mathematical expressions for circuit responses. The response models can then be used to quantify response trade-offs, optimize designs, and minimize circuit variations. The use of this methodology puts the designer's intelligence back into design optimization while making “designing for circuit manufacturability” a more systematic and straightforward process. The method improves the design process, circuit performance, and manufacturability. Two design examples are presented in context to the new design methodology 相似文献
34.
There is now strong evidence that the chorioretinal degeneration associated with ornithine-delta-aminotransferase (OAT) deficiency is a consequence of hyperornithinemia. Therefore development of a metabolic system for clearing ornithine from the circulation is being pursued as a potential treatment. The skin is considered an attractive location for such a metabolic system because autologous cells can be safely and easily utilized. This study was undertaken to determine the ornithine metabolizing capacity of epidermal keratinocytes expressing normal and superphysiologic amounts of OAT. The data show that overexpression of OAT in keratinocytes cultured from a gyrate atrophy patient restores ornithine metabolism and results in a rate of ornithine disappearance from the medium that is significantly higher than the rate of disappearance from the medium bathing normal keratinocytes. In addition, OAT activity determined in soluble protein prepared from sonicates suggests that the capacity to maintain plasma ornithine within the normal range is contained within an accomplishable graft of keratinocytes overexpressing OAT. However, the actual rate of ornithine disappearance from the media was significantly less than predicted from enzyme activity assays. Following ornithine metabolite production by intact cells suggests that ornithine metabolism is limited primarily by clearance of downstream metabolites, as opposed to substrate delivery. 相似文献
35.
36.
37.
KE Ensrud DM Black L Palermo DC Bauer E Barrett-Connor SA Quandt DE Thompson DB Karpf 《Canadian Metallurgical Quarterly》1997,157(22):2617-2624
BACKGROUND: The efficacy of antiresorptive therapy in preventing fractures in women at highest fracture risk, such as very elderly women or those with severe osteoporosis, is uncertain. PARTICIPANTS AND METHODS: Using data from a double-blind, randomized, placebo-controlled clinical trial that enrolled 2027 postmenopausal women aged 55 to 81 years with low femoral neck bone mineral density (BMD) and existing vertebral fractures, we examined the consistency of the effect of treatment with alendronate sodium in preventing fractures within a priori-specified risk subgroups defined at baseline by age, bone density, number of preexisting vertebral fractures, and history of postmenopausal fracture. The women were randomized to oral administration of alendronate or placebo and followed up for an average of 2.9 years. The initial dose of alendronate sodium was 5 mg/d; the dosage was increased from 5 to 10 mg/d at 24 months. New vertebral fractures, the primary end point of this arm of the trial, were defined by morphometry as a decrease of 20% and at least 4 mm in any vertebral height between baseline and a follow-up radiograph at 36 months. Incident clinical fractures, the secondary end point, included nonspine and clinical (symptomatic) vertebral fractures. All clinical fractures were confirmed with x-ray film reports or, in the case of clinical vertebral fractures, x-ray films. RESULTS: Overall, there was a 47% significant reduction in risk of new vertebral fractures in the alendronate group compared with the placebo group. The reduction in risk of new vertebral fracture was consistent across fracture risk categories including age (relative risk [RR], 0.49 in women < 75 years compared with 0.62 in those > or = 75 years), BMD (RR, 0.54 in women with a femoral neck BMD < 0.59 g/cm2 [median] compared with 0.53 in those with a BMD > or = 0.59 g/cm2), and number of preexisting vertebral fractures (RR, 0.58 in women with 1 vertebral fracture compared with 0.52 in those with > or = 2). The overall significant 28% reduction in risk of incident clinical fractures in the alendronate group compared with the placebo group was also observed within these subgroups. Compared with the number of lower-risk women, a similar or smaller number of high-risk women needed to be treated to prevent 1 fracture. For example, 8 women aged 75 years or older compared with 9 women younger than 75 years, or 4 women with 2 or more existing vertebral fractures compared with 16 women with 1 existing vertebral fracture, needed to be treated with alendronate for 5 years to prevent 1 new vertebral fracture. CONCLUSIONS: Alendronate effectively reduces fracture risk in postmenopausal women with vertebral fractures and low BMD, including those women at highest risk because of advanced age or severe osteoporosis. Since the risk reductions observed with alendronate treatment were consistent within fracture risk categories, more fractures were prevented by treating women at highest risk. 相似文献
38.
39.
40.